Groundbreaking assay platform for neurodegenerative disease research
Progressive neuronal cell loss in the human brain is the pathological hallmark of several neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Insights into the early processes triggering the neurodegenerative disease cascade is fundamental to the development of highly differentiated therapeutics for these diseases.
By employing our complex in vitro disease models, target modulation and expression technologies, and proprietary readouts, we create highly innovative assays for target identification and validation, and lead discovery.
We engage with our Clients to establish research programs, where functional and morphological screening assays are applied for the identification of novel targets and unique lead compounds with the aim of achieving new treatment options for neurodegenerative diseases.